What is MRSA (Methicillin-Resistant Staphylococcus Aureus)?
Methicillin-resistant Staphylococcus aureus (MRSA) is a bacteria responsible for several difficult-to-treat infections. By definition, it is any strain of Staphylococcus aureus bacteria that has developed resistance to specific antibiotic medications.
What do patients take to treat MRSA (Methicillin-Resistant Staphylococcus Aureus) and its symptoms?
Commonly prescribed and frequently used treatments
| Treatment name | Efficacy | Overall rating of side effects | # of Evaluations |
|---|---|---|---|
|
Vancomycin
(Vancocin)
|
2 | ||
|
Clindamycin
(Evoclin, Clindamycin Topical, Cleocin Phosphate, Clindamycin PH 1% Gel)
|
2 | ||
|
Doxycycline
(Doxyferm, Doxsig, Doryx, Oracea)
|
2 | ||
|
Minocycline
(Minoclin, Minocin, Akamin)
|
0 | ||
|
Sulfamethoxazole-Trimethoprim (cotrimoxazole)
(Bactrim DS, Sulfatrim, SMZ-TMP DS, Sulfatrim Pediatric)
|
0 |
These charts show data from MRSA (Methicillin-Resistant Staphylococcus Aureus) patients' latest treatment evaluations
Who has MRSA (Methicillin-Resistant Staphylococcus Aureus) at PatientsLikeMe?
- 91 patients have this condition
- 4 New patients joined this month
- 2 say MRSA (Methicillin-Resistant Staphylococcus Aureus) is their primary condition
| <20 | 20-29 | 30-39 | 40-49 | 50-59 | 60-69 | 70+ |
|---|---|---|---|---|---|---|
| Current Age | ||||||
| Gender | |
| 85% | Females |
|---|---|
| 15% | Males |
| Age at first symptom | # of patients | Proportion |
|---|---|---|
| 0-19 yrs | 6 | |
| 20-29 yrs | 2 | |
| 30-39 yrs | 6 | |
| 40-49 yrs | 9 | |
| 50-59 yrs | 5 | |
| 60-69 yrs | 1 | |
| 70+ yrs | 0 |
These charts show data from MRSA (Methicillin-Resistant Staphylococcus Aureus) patients who have completed their condition history